Trial Profile
KD-295 phase II study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2022
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions; Therapeutic Use
- 23 Feb 2015 New trial record